Follow Japan University News

Press releases View all 20 hits

Slack for higher education: Kindai to Become First Japanese University to Invigorate University-wide Communications and Smoothen the Delivery of Online Classes - Kindai University

Slack for higher education: Kindai to Become First Japanese University to Invigorate University-wide Communications and Smoothen the Delivery of Online Classes - Kindai University

Press releases   •   Jun 30, 2020 01:11 UTC

- Introduction of Slack aims to build a new communication platform for staff and students institution wide - Utilization of Slack enhances the effectiveness of distance learning solutions - Expansion of student support through user-friendly Slack

Efficacy of Opdivo (Nivolumab) in Cancer of Unknown Primary Cases Confirmed - Kindai University

Efficacy of Opdivo (Nivolumab) in Cancer of Unknown Primary Cases Confirmed - Kindai University

Press releases   •   Jun 11, 2020 08:53 UTC

- Efficacy of molecular target drug Nivolumab verified in investigator-initiated clinical trial for use with CUP by hospital team from Kindai University’s Faculty of Medicine - Reductions by more than half in tumor size in over 20% of CUP patients observed - Nivolumab expected to become standard treatment for CUP cases with no standard treatment

ALMA Resolves Gas Impacted by Young Jets from Supermassive Black Hole - Kindai University

ALMA Resolves Gas Impacted by Young Jets from Supermassive Black Hole - Kindai University

Press releases   •   Mar 27, 2020 10:00 UTC

Astronomers obtained the first resolved image of disturbed gaseous clouds in a galaxy 11 billion light years away by using ALMA. The team found that the disruption is caused by young powerful jets ejected from a supermassive black hole residing at the center of the host galaxy. This result will cast light on the mystery of the evolutionary process of galaxies in the early Universe.

Preclinical Stage Verification for Combined Use of a Drug Under Development with an Existing Drug to Stimulate the Immune System to Attack Cancer Cells - Kindai University

Preclinical Stage Verification for Combined Use of a Drug Under Development with an Existing Drug to Stimulate the Immune System to Attack Cancer Cells - Kindai University

Press releases   •   Nov 01, 2019 05:00 UTC

The research team from Kindai University's Faculty of Medicine, in cooperation with DAIICHI SANKYO COMPANY, LIMITED, have verified at the preclinical stage that using the currently under-development anti-cancer drug, U3-1402*1, in combination with immune checkpoint inhibitors*2 has the potential to be an effective treatment.

Contacts 2 hits